Cambridge Nutritional Sciences (LON:CNSL – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported GBX (0.30) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 236 million for the quarter. Cambridge Nutritional Sciences had a negative return on equity of 69.62% and a negative net margin of 83.53%.
Cambridge Nutritional Sciences Stock Down 1.4%
CNSL stock opened at GBX 1.38 on Wednesday. Cambridge Nutritional Sciences has a 52 week low of GBX 1.25 and a 52 week high of GBX 2.50. The firm has a market capitalization of £3.28 million, a P/E ratio of -0.57 and a beta of 1.91. The company has a fifty day simple moving average of GBX 1.55 and a two-hundred day simple moving average of GBX 1.80.
Cambridge Nutritional Sciences Company Profile
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
See Also
- Five stocks we like better than Cambridge Nutritional Sciences
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
Receive News & Ratings for Cambridge Nutritional Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Nutritional Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
